Literature DB >> 1299377

p53 gene mutation in primary human renal cell carcinoma.

S Torigoe1, T Shuin, Y Kubota, T Horikoshi, K Danenberg, P V Danenberg.   

Abstract

We searched for possible mutations in the entire coding region of tumor suppressor gene p53 in primary human renal cell carcinomas using polymerase chain reaction and single-strand conformational polymorphism analysis of RNA. We found p53 mutations in 2 of 21 cases (10%). DNA sequencing of the polymerase chain reaction products verified that the first case included a 17-base deletion at the beginning of exon 6. The second case showed a T to C transition at nucleotide 1328 in exon 7. No clinical or pathological similarity was found in the renal cell carcinomas containing the mutated p53 genes. Present results suggest that p53 mutation is involved at low frequency in human renal cell carcinomas.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1299377

Source DB:  PubMed          Journal:  Oncol Res        ISSN: 0965-0407            Impact factor:   5.574


  5 in total

Review 1.  p53 and MDM2 in renal cell carcinoma: biomarkers for disease progression and future therapeutic targets?

Authors:  Aidan P Noon; Nikolina Vlatković; Radosław Polański; Maria Maguire; Howida Shawki; Keith Parsons; Mark T Boyd
Journal:  Cancer       Date:  2010-02-15       Impact factor: 6.860

2.  Drug-induced torsades de pointes in an underserved urban population. Methadone: is there therapeutic equipoise?

Authors:  Jorge Romero; Samuel H Baldinger; David Goodman-Meza; Krysthel Engstrom; Carolina R Valencia; Anjani Golive; Francisco Medrano; Sabarivinoth Rangasamy; Mohammed Makkiya; John D Fisher; Jay Gross; Andrew Krumerman; Soo Kim; Mario J Garcia; Luigi Di Biase; Kevin J Ferrick
Journal:  J Interv Card Electrophysiol       Date:  2015-11-20       Impact factor: 1.900

3.  Integrated epigenomic profiling reveals endogenous retrovirus reactivation in renal cell carcinoma.

Authors:  Kyle T Siebenthall; Chris P Miller; Jeff D Vierstra; Julie Mathieu; Maria Tretiakova; Alex Reynolds; Richard Sandstrom; Eric Rynes; Eric Haugen; Audra Johnson; Jemma Nelson; Daniel Bates; Morgan Diegel; Douglass Dunn; Mark Frerker; Michael Buckley; Rajinder Kaul; Ying Zheng; Jonathan Himmelfarb; Hannele Ruohola-Baker; Shreeram Akilesh
Journal:  EBioMedicine       Date:  2019-03-01       Impact factor: 8.143

4.  Molecular genetic investigation of sporadic renal cell carcinoma: analysis of allele loss on chromosomes 3p, 5q, 11p, 17 and 22.

Authors:  K Foster; P A Crossey; P Cairns; J W Hetherington; F M Richards; M H Jones; E Bentley; N A Affara; M A Ferguson-Smith; E R Maher
Journal:  Br J Cancer       Date:  1994-02       Impact factor: 7.640

5.  Benign and malignant renal cells are differentially inhibited during prolonged organ preservation.

Authors:  Nengwang Yu; Shuai Fu; Yubao Liu; Yibao Liu; Zhihou Fu; Jianzhong Meng; Zhonghua Xu; Baocheng Wang; Aimin Zhang
Journal:  PLoS One       Date:  2013-12-09       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.